Literature DB >> 14481310

Cataracts in rheumatoid arthritis patients treated with corticosteroids. Description and differential diagnosis.

R B OGLESBY, R L BLACK, L VON SALLMANN, J J BUNIM.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES/toxicology; ARTHRITIS, RHEUMATOID/therapy; CATARACT/etiology

Mesh:

Substances:

Year:  1961        PMID: 14481310     DOI: 10.1001/archopht.1961.00960010521013

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  8 in total

1.  Posterior subcapsular lens opacities in patients on longterm corticosteroid therapy.

Authors:  S J CREWS
Journal:  Br Med J       Date:  1963-06-22

2.  Posterior subcapsular cataracts as a complication of adrenocortical steroid therapy.

Authors:  J H TOOGOOD; C DYSON; C A THOMPSON; E J MULARCHYK
Journal:  Can Med Assoc J       Date:  1962-01-13       Impact factor: 8.262

3.  Eyes after renal transplantation.

Authors: 
Journal:  Br Med J       Date:  1972-07-15

4.  Distribution and movement of ions in the ocular lens.

Authors:  C A Paterson
Journal:  Doc Ophthalmol       Date:  1972-04-15       Impact factor: 2.379

5.  Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy. In patients with rheumatoid arthritis and related conditions.

Authors:  J Williamson; R W Paterson; D D McGavin; M K Jasani; J A Boyle; W M Doig
Journal:  Br J Ophthalmol       Date:  1969-06       Impact factor: 4.638

6.  The temperature-reversible cation shift of the lens.

Authors:  J E Harris
Journal:  Trans Am Ophthalmol Soc       Date:  1966

7.  Cortisone cataract in children with nephrotic syndrome.

Authors:  H J Bachmann; P Schildberg; H Olbing; D Krämer; T Waubke
Journal:  Eur J Pediatr       Date:  1977-03-18       Impact factor: 3.183

8.  Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews.

Authors:  Yun-Kyoung Song; Junu Song; Kyungim Kim; Jin-Won Kwon
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.